
|Videos|October 27, 2011
Dr. Scagliotti Gives 3 Important Lung Cancer Takeaway Points
Author(s)Giorgio V. Scagliotti, MD, PhD
Dr. Giorgio Scagliotti from the University of Turin Gives 3 Important Lung Cancer Takeaway Points
Advertisement
Giorgio V. Scagliotti, MD, PhD, head of the Thoracic Oncology Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy, explains 3 lung cancer topics that require more awareness and research to produce optimal results in the future.
- Regardless of the cost a connection between early lung cancer detection and lower mortality needs to be established.
- To ensure the best treatment and diagnosis physicians need to refer every new patient with lung cancer to a multidisciplinary clinic.
- Further genomic investigation is needed and can increase survival in at least 30% of patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5


































